Ultimately, the study of Boström and Colleagues opens new possibilities and the ability to specifically target the expression of MMP-1, a particular MMP involved in BC initiation/progression, aberrantly expressed in the metastatic process, suggesting further diagnostic, prognostic and therapeutic potential. This evidence concerns the gene MMP1 and breast cancer.